HY Medical is one of the leading healthcare AI solution developers, dedicated to applying computer vision and deep learning technologies to the medical field. We are an early member of the Intel AI Builders Program and in 2018 we became one of the Intel capital portfolio companies. As one of the early AI companies focusing on medical imaging, HY medical has released 10+ AI assisted screening & diagnosis applications. For example, we developed solutions for Lung nodules detection, Tuberculosis screening, bone fracture detection and breast cancer detection, etc. Those solutions have been deployed in over 1,000 hospitals and healthcare institutions in China over the past 5 years and our customer base is still growing. Collaborating with Intel, we expanded our market reach globally, now our solutions are implemented in 80 hospitals overseas.